-
effectivehealthcare.ahrq.gov/products/vitamin-d-calcium/research
September 15, 2014 - Structured Abstract
Background
In 2009, the Institute of Medicine/Food and Nutrition Board constituted
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
October 01, 2010 - Food and Drug Administration has approved
rFVIIa for the treatment and prevention of bleeding in
patients
-
effectivehealthcare.ahrq.gov/products/infantile-hemangioma/policymaker
June 21, 2016 - Food and Drug Administration as treatment for IH.
-
effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/consumer
August 31, 2016 - Food and Drug Administration (FDA) approves medicines for certain uses. … Food and Drug Administration
*More research is needed to know this for sure. † More research is
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_consumer.pdf
August 01, 2016 - Food and Drug Administration (FDA) approves medicines for certain uses. … Food and Drug Administration
* More research is needed to know this for sure.
-
effectivehealthcare.ahrq.gov/products/ischemic-stroke-treatment/research-protocol
February 19, 2010 - subsequently dissolving the clot. 15 Intravenous (IV) rtPA has been approved by the United States Food … A neurothrombectomy device is defined by the Food and Drug Adminstration (FDA) as a device intended to … Food and Drug Administration
GOS
Glascow Outcome Scale
IA
Intraarterial
ICH
Intracerebral
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_consumer.pdf
May 01, 2017 - Food and Drug Administration (FDA) lists the following
possible side effects of antibiotics to treat … They come in
some foods, such as yogurt, kefir (a drink made from fermented
milk), soy drinks, buttermilk
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ischemic-stroke-treatment_research-protocol.pdf
February 19, 2010 - subsequently dissolving the clot.15 Intravenous (IV) rtPA has been approved by the United
States Food … A
neurothrombectomy device is defined by the Food and Drug Adminstration (FDA) as a device
intended … Food and Drug Administration
GOS Glascow Outcome Scale
IA Intraarterial
ICH Intracerebral
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - called alpha-MSH, and
naltrexone, which inhibits beta-endorphin, a natural opiate believed to increase food … It is a 60-cm
impermeable sleeve that allows partially digested food leaving the stomach to move … development, with several innovative mechanisms of action
under way that are intended to decrease food … Food and Drug Administration (FDA). … The device is a 60-cm impermeable sleeve that allows chyme (partially digested food leaving the
stomach
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
May 01, 2009 - Drug use for indications not approved by the Food and Drug Administration
exceeds 20% of outpatient … Effective Health Care Research Report Number 12
1
Introduction
The United States Food and Drug … Food and Drug Administration, Center for
Drug Evaluation and Review. … /Drug Safety
Diane Kennedy, RPh, MPH Food and Drug Administration Regulator/Drug Analysis
Laurie … Burke, RPh, MPH Food and Drug Administration Regulator/Drug Labeling and Marketing
Daniel J.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - Food and Drug Administration (FDA) guidelines set for CLS
studies. … Food enters only the upper portion (the gastric pouch). … The distal small intestine is
connected to the gastric pouch, permitting the emptying of food. … Food
and Drug Administration (FDA); 2011 Feb 16
[accessed 2011 May 23]. [2 p]. … Food and Drug Administration extends
action date for dapagliflozin by three months.
[website].
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - Food and Drug Administration (FDA) guidelines set for CLS
studies. … Food enters only the upper portion (the gastric pouch). … The distal small intestine is
connected to the gastric pouch, permitting the emptying of food. … Food
and Drug Administration (FDA); 2011 Feb 16
[accessed 2011 May 23]. [2 p]. … Food and Drug Administration extends
action date for dapagliflozin by three months.
[website].
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
October 01, 2015 - Nintedanib is administered 150 mg orally, twice daily, with
food. … Food
and Drug Administration (FDA); 2014 Oct 15
[accessed 2014 Oct 16]. [4 p]. … Food
and Drug Administration (FDA); 2014 Oct 15
[accessed 2014 Dec 11]. [5 p]. … Food
and Drug Administration (FDA); 2014 Sep 04
[accessed 2014 Sep 08]. [5 p]. … Food and Drug
Administration (FDA); 2014 Aug 12 [accessed 2014
Sep 08]. [5 p].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_executive.pdf
September 01, 2009 - Food and Drug Administration for
this indication and tibolone is not. … • A Gail score of ≥1.66 percent has been used as a
risk threshold in prevention trials and in Food
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-protocol-appendix-a.pdf
March 12, 2024 - dog[title] OR dogs[title] OR rat[title] OR
rats[title] OR canine[title] OR chicken*[title] OR "dog food
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Food and Drug
Administration (FDA) approved the Sedasys system in May 2013 through the premarket … Food and Drug
Administration (FDA); 2009 May 28. 32 p. … Food and Drug Administration (FDA).
510(k) summary for Raisin personal monitor
[K093976]. … Food and Drug Administration (FDA); 2010
Mar 25 [accessed 2010 Dec 27]. [10 p]. … Food and Drug Administration (FDA);
2012 May 14. 10 p.
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
October 01, 2015 - Nintedanib is administered 150 mg orally, twice daily, with food. … Food and Drug Administration (FDA). … Food
and Drug Administration (FDA); 2014 Jun 30
[accessed 2014 Jul 11]. [1 p]. … Food
and Drug Administration (FDA); 2014 Oct 15
[accessed 2014 Oct 16]. [4 p]. … Food
and Drug Administration (FDA); 2014 Oct 15
[accessed 2014 Dec 11]. [5 p].
-
effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
January 01, 2012 - Food and Drug
Administration (FDA) for treating obesity were expressed in September 2011 by the U.S … called alpha-MSH, and naltrexone, which inhibits beta-endorphin, a natural opiate
believed to increase food … It is a 60-
cm impermeable sleeve that allows partially digested food leaving the stomach to move … Food and
Drug Administration (FDA). … The device is a 60-cm impermeable sleeve that allows chyme (partially digested food leaving the
stomach
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Food and Drug Administration (FDA) for
treating obesity are discussed below. … Food and Drug Administration (FDA); 2015 Jul
29 [accessed 2015 Jul 30]. [5 p]. … Food and Drug Administration
(FDA); 2015 Jul 28 [accessed 2015 Jul 30]. [5
p]. … Food and Drug Administration (FDA); 2012 Jul
17 [accessed 2015 Feb 03]. [2 p]. … Food and Drug Administration (FDA); 2014
Dec 23 [accessed 2015 Feb 03]. [5 p].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_disposition-comments.pdf
March 20, 2013 - outcome measures: Pediatric
Motor Activity Log (PMAL) includes items like holding a
cup, eating finger foods … of comparative studies into other nutritional
interventions (eg positioning, texture modification, food … We excluded this study as an observation of the
association of food consistency on swallowing, rather … is disappointing
that no studies met the AHRQ criteria to address this
question, although pureed food